What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Surgery
- Diabetes mellitus
T. Alp Ikizler focuses on Internal medicine, Kidney disease, Hemodialysis, Dialysis and Surgery.
The various areas that T. Alp Ikizler examines in his Internal medicine study include Gastroenterology and Endocrinology.
His Kidney disease study combines topics from a wide range of disciplines, such as Body mass index, Oxidative stress, Diabetes mellitus, Creatinine and Wasting.
His work deals with themes such as Interquartile range, Fistula, Randomized controlled trial, Intensive care medicine and Acute kidney injury, which intersect with Dialysis.
His research integrates issues of Platelet aggregation inhibitor, Confidence interval and Risk factor in his study of Surgery.
His study in Renal function is interdisciplinary in nature, drawing from both Physical therapy, Transplantation and Veterans Affairs.
His most cited work include:
- K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification (9292 citations)
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia (973 citations)
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia (973 citations)
What are the main themes of his work throughout his whole career to date?
T. Alp Ikizler spends much of his time researching Internal medicine, Kidney disease, Hemodialysis, Intensive care medicine and Endocrinology.
His study involves Nephrology, Prospective cohort study, Renal function, Dialysis and Acute kidney injury, a branch of Internal medicine.
His studies in Kidney disease integrate themes in fields like Cohort study, Diabetes mellitus, Uremia, Disease and Wasting.
His Hemodialysis study combines topics from a wide range of disciplines, such as Gastroenterology, Oxidative stress and Cardiology.
T. Alp Ikizler interconnects Psychological intervention, Mortality rate, MEDLINE and Malnutrition in the investigation of issues within Intensive care medicine.
His Endocrinology research is multidisciplinary, incorporating perspectives in Inflammation and Protein catabolism.
He most often published in these fields:
- Internal medicine (82.19%)
- Kidney disease (48.49%)
- Hemodialysis (37.26%)
What were the highlights of his more recent work (between 2018-2021)?
- Internal medicine (82.19%)
- Kidney disease (48.49%)
- Hemodialysis (37.26%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Internal medicine, Kidney disease, Hemodialysis, Dialysis and Intensive care medicine.
His study in Cohort, Nephrology, Renal function, Cohort study and End stage renal disease falls within the category of Internal medicine.
His studies deal with areas such as Urology, Diabetes mellitus, Hazard ratio, Acute kidney injury and Prospective cohort study as well as Kidney disease.
The Hemodialysis study combines topics in areas such as Cardiology, Randomized controlled trial, Mitochondrion and Skeletal muscle.
The concepts of his Dialysis study are interwoven with issues in Inflammation, Systemic inflammation, Anesthesia and Peritoneal dialysis.
His Intensive care medicine research includes themes of Evidence-based medicine and MEDLINE.
Between 2018 and 2021, his most popular works were:
- KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update (87 citations)
- COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis. (51 citations)
- Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference (48 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Surgery
- Disease
T. Alp Ikizler mainly focuses on Internal medicine, Dialysis, Kidney disease, Hemodialysis and Intensive care medicine.
His Acquired immune system research extends to Internal medicine, which is thematically connected.
T. Alp Ikizler has researched Dialysis in several fields, including Randomized controlled trial, Spironolactone, Hyperkalemia, Systemic inflammation and Receptor antagonist.
In his study, Prospective cohort study, Hazard ratio and Renal function is strongly linked to Acute kidney injury, which falls under the umbrella field of Kidney disease.
His Hemodialysis study integrates concerns from other disciplines, such as Sarcopenia, Anesthesia, Discontinuation, Tolerability and Skeletal muscle.
His Intensive care medicine research integrates issues from Dialysis patients, Evidence-based medicine and Peritoneal dialysis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
